Summary & Overview

HCPCS S8030: Scleral Tantalum Ring Localization for Proton Therapy

HCPCS Level II code S8030 denotes the scleral application of tantalum ring(s) to localize lesions for proton beam therapy. This procedure is used to precisely mark ocular or periocular targets to enable accurate proton radiation delivery, which is critical for sparing surrounding healthy structures and maximizing therapeutic effect. Nationally, the code captures a specialized, low-volume but high-precision adjunct to proton radiotherapy for ocular tumors and select periocular lesions.

Key payers in the analysis include Aetna, Blue Cross Blue Shield, Cigna, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context and service setting, common billing modifiers associated with the service, and what is and is not available in the input data. The publication addresses coverage and billing considerations at a national level, including typical sites of service and ancillary documentation expectations.

The article explains what S8030 represents, why precise localization matters for proton beam therapy, and where the procedure is typically performed. It also outlines which payers are part of the coverage discussion and notes gaps where input data did not provide specific taxonomies, ICD-10 diagnoses, related codes, or payer-specific edits. Data not available in the input is identified clearly for readers seeking further operational detail.

AetnaBlue Cross Blue ShieldCignaUnitedHealthcareMedicareS8030HCPCS Level IIproton beam therapyocular localizationradiation oncologytantalum ringscleral procedure

Billing Code Overview

HCPCS Level II code S8030 describes the scleral application of tantalum ring(s) for localization of lesions for proton beam therapy. The procedure involves placement of tantalum rings on the sclera to mark or localize ocular or periocular lesions to guide targeted proton beam delivery. This service is a procedural localization technique performed in conjunction with proton radiation planning and delivery.

Service type: Localization procedure for radiation therapy
Typical site of service: Hospital outpatient department or specialized radiation oncology suite

Clinical & Coding Specifications

Clinical Context

A 58-year-old patient with a small, localized choroidal melanoma is scheduled for proton beam therapy. To ensure precise dosimetric targeting and reproducible treatment geometry, ocular oncology and radiation oncology coordinate a minor surgical procedure in the ophthalmology operating suite. Under monitored anesthesia care or local anesthesia with sedation, the ocular surgeon places one or more scleral tantalum localization rings sutured to the episclera surrounding the lesion. The tantalum markers are radiopaque and serve as fiducial landmarks for planning CT/MRI simulation and daily alignment during proton beam delivery. After marker placement, the patient undergoes simulation imaging with immobilization (custom head mask and eye fixation) and the radiation oncology team creates the treatment plan. The tantalum rings remain in place for the duration of the fractionated proton therapy course, and the patient is monitored for ocular discomfort, infection, or wound complications during follow-up visits.

Coding Specifications

Modifier	Description	When to Use
`22`	Increased procedural services	Use when the scleral tantalum ring placement requires substantially greater work than typical (unusual complexity).
`23`	Unusual anesthesia	Use when general anesthesia is required for this minor ocular procedure in a patient with exceptional circumstances.
`50`	Bilateral procedure	Use when tantalum rings are placed on both eyes during the same operative session.
`52`	Reduced services	Use when the procedure is partially reduced or not completed as planned.
`53`	Discontinued procedure	Use when the procedure is started but terminated due to extenuating circumstances or patient safety concerns.
`56`	Preoperative assessment only	Use when only preoperative workup is performed and the implantation is deferred.
`62`	Two surgeons	Use when the complexity necessitates two surgeons working together for placement.
`66`	Surgical team	Use when a formal surgical team (e.g., with assistant surgeons) is used for care.
`73`	Discontinued outpatient procedure prior to anesthesia	Use when the outpatient procedure is cancelled after patient preparation but before anesthesia induction.
`78`	Return to OR for unrelated procedure during global period	Use when the patient returns to the operating room for a related complication during the postoperative global period and reimbursement rules require the modifier.
`80`	Assistant surgeon	Use when an assistant surgeon performs a portion of the procedure and is eligible for separate payment.
`81`	Minimum assistant surgeon	Use when the assistant's participation is minimal but documented.
`82`	Assistant surgeon (when a qualified resident surgeon is unavailable)	Use when an assistant surgeon is required because a resident is not available.
`AS`	Physician assistant, nurse practitioner, or clinical nurse specialist	Use when a qualified nonphysician practitioner performs part of the service as allowed by payer policy.

Taxonomy Code	Specialty	Notes
207P00000X	Ophthalmology	Ocular oncology and surgical placement of scleral markers are performed by ophthalmologists with subspecialty expertise.
2084P0800X	Radiation Oncology	Radiation oncologists coordinate simulation and treatment planning that utilize tantalum fiducials.
2086S0105X	Surgical Oncology	Surgical oncologists involved in ocular tumor management may participate in multidisciplinary cases.
363A00000X	Certified Registered Nurse Anesthetist	Anesthesia services for ophthalmic procedures, when needed, are provided by CRNAs.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`C69.3`	Malignant neoplasm of choroid	Primary indication for proton beam therapy with scleral tantalum ring localization for precise targeting.
`C69.2`	Malignant neoplasm of retina	May require precise localization for radiotherapy when ocular tumors are posteriorly located.
`D03.5`	Melanoma in situ of choroid	Lesions requiring close monitoring and sometimes focal therapy; fiducials assist in planning when radiation is considered.
`D49.7`	Neoplasm of uncertain behavior of eye, adnexa, and orbit	When behavior is uncertain, localization aids in biopsy guidance and potential localized radiation.
`H44.3`	Endophthalmitis, not elsewhere classified	Postoperative infectious complication to monitor for after scleral implantation; important for differential during follow-up.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`67811`	Cryotherapy of retina and/or choroid, single application; external	May be performed by ocular oncology prior to or after fiducial placement for local tumor control in selected cases.
`67025`	Incision of retina, removal of foreign body; external (scleral)	Related to scleral surgical access techniques; shares operative approach concepts though not typically performed concurrently.
`67221`	Photocoagulation, laser, retina; focal, one or more sessions	May be used adjunctively in management of choroidal lesions in the overall treatment plan alongside proton therapy.
`67700`	Biopsy of eyelid or external eye; full-thickness	Diagnostic biopsy codes that may precede definitive proton therapy and marker placement.
`77334`	Radiation therapy planning, simple or complex (delivery of proton therapy planning and dosimetry)	Directly related to proton beam treatment planning that uses the tantalum markers for localization.